FDA approves Sarasota firm's dry-eye test

By Business Observer Staff
| 3:14 p.m. November 27, 2013
| 0 Free Articles Remaining!

Manatee-Sarasota

LAKEWOOD RANCH — The U.S. Food and Drug Administration cleared InflammaDry, a product Rapid Pathogen Screening designed to quickly test for dry-eye disease, for nationwide sales.

Continue reading your article
with a Business Observer subscription.

What's included:

✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition
✓ Mailed print newspaper every Friday (optional)
✓ Newsletter of daily business news

Latest News

February 7, 2026

Tampa airport unveils final design for new $1.5B airside terminal

February 7, 2026

Report: NY, Idaho among feeder states for Sarasota, Manatee growth

February 6, 2026

Southwest Florida homebuilder dies at 91

February 6, 2026

FDA approves Sarasota firm's dry-eye test

Continue reading your article
with a Business Observer subscription.

Sponsored Content

DC homebuilder buys Pasco County school land for $11M

Report: NY, Idaho among feeder states for Sarasota, Manatee growth

After changes, Boar’s Head reopens plant tied to listeria outbreak

Bradenton used car lot sells for $1.25M

Tampa firm invests $5.5M into Sarasota townhome project

Rock star sells Sarasota estate for $7.5 million

0 Articles Remaining!

Not a Subscriber?

Already a Subscriber?

FDA approves Sarasota firm's dry-eye test

Continue reading your article with a Business Observer subscription.

Latest News

Sponsored Content

0 Articles Remaining!

Not a Subscriber?

Already a Subscriber?

Sign Up for Daily Brief

Sign Up for CRE Central

Continue reading your article
with a Business Observer subscription.